BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9262670)

  • 1. Colonic nitrite and immunoglobulin G concentrations in dogs with inflammatory bowel disease.
    Gunawardana SC; Jergens AE; Ahrens FA; Niyo Y
    J Am Vet Med Assoc; 1997 Aug; 211(3):318-21. PubMed ID: 9262670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphometric evaluation of immunoglobulin A-containing and immunoglobulin G-containing cells and T cells in duodenal mucosa from healthy dogs and from dogs with inflammatory bowel disease or nonspecific gastroenteritis.
    Jergens AE; Moore FM; Kaiser MS; Haynes JS; Kinyon JM
    Am J Vet Res; 1996 May; 57(5):697-704. PubMed ID: 8723885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of lymphocyte apoptosis in dogs with inflammatory bowel disease.
    Dandrieux JR; Bornand VF; Doherr MG; Kano R; Zurbriggen A; Burgener IA
    Am J Vet Res; 2008 Oct; 69(10):1279-85. PubMed ID: 18828683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
    Münster M; Hörauf A; Bilzer T
    Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
    Fagerberg UL; Lööf L; Lindholm J; Hansson LO; Finkel Y
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic inflammatory bowel disease in dogs and cats: 84 cases (1987-1990).
    Jergens AE; Moore FM; Haynes JS; Miles KG
    J Am Vet Med Assoc; 1992 Nov; 201(10):1603-8. PubMed ID: 1289345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Kayazawa M; Saitoh O; Kojima K; Nakagawa K; Tanaka S; Tabata K; Matsuse R; Uchida K; Hoshimoto M; Hirata I; Katsu K
    Am J Gastroenterol; 2002 Feb; 97(2):360-9. PubMed ID: 11866274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM; Grellet A; Allenspach K; Lecoindre P; Day MJ; Priestnall SL; Toresson L; Procoli F; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):156-66. PubMed ID: 24518653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2/caspase 3 mucosal imbalance favors T cell resistance to apoptosis in dogs with inflammatory bowel disease.
    Jergens A; Young J; Moore D; Wang C; Hostetter J; Augustine L; Allenspach K; Schmitz S; Mosher C
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):167-74. PubMed ID: 24495616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abundance of mRNA of growth hormone receptor and insulin-like growth factors-1 and -2 in duodenal and colonic biopsies of dogs with chronic enteropathies*.
    Spichiger AC; Allenspach K; Ontsouka E; Gaschen F; Morel C; Blum JW; Sauter SN
    J Vet Med A Physiol Pathol Clin Med; 2005 Dec; 52(10):491-7. PubMed ID: 16300656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD11c+ cells are significantly decreased in the duodenum, ileum and colon of dogs with inflammatory bowel disease.
    Kathrani A; Schmitz S; Priestnall SL; Smith KC; Werling D; Garden OA; Allenspach K
    J Comp Pathol; 2011 Nov; 145(4):359-66. PubMed ID: 21592490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum calprotectin concentrations in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM; Jergens AE; Ackermann MR; Barr JW; Suchodolski JS; Steiner JM
    Am J Vet Res; 2012 Dec; 73(12):1900-7. PubMed ID: 23176415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic lymphocyte and plasma cell populations in dogs with lymphocytic-plasmacytic colitis.
    Jergens AE; Gamet Y; Moore FM; Niyo Y; Tsao C; Smith B
    Am J Vet Res; 1999 Apr; 60(4):515-20. PubMed ID: 10211698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear receptor and target gene mRNA abundance in duodenum and colon of dogs with chronic enteropathies.
    Greger DL; Gropp F; Morel C; Sauter S; Blum JW
    Domest Anim Endocrinol; 2006 Nov; 31(4):327-39. PubMed ID: 16446074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of P-glycoprotein in the intestinal epithelium of dogs with lymphoplasmacytic enteritis.
    Van der Heyden S; Vercauteren G; Daminet S; Paepe D; Chiers K; Polis I; Waelbers T; Hesta M; Schauvliege S; Wegge B; Ducatelle R
    J Comp Pathol; 2011; 145(2-3):199-206. PubMed ID: 21334003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunohistochemical study of histiocytic ulcerative colitis in boxer dogs.
    German AJ; Hall EJ; Kelly DF; Watson AD; Day MJ
    J Comp Pathol; 2000; 122(2-3):163-75. PubMed ID: 10684685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel disease.
    McCann TM; Ridyard AE; Else RW; Simpson JW
    J Small Anim Pract; 2007 Nov; 48(11):620-5. PubMed ID: 17608662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
    Siddique I; Hasan F; Khan I
    Scand J Gastroenterol; 2009; 44(1):56-64. PubMed ID: 18785066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.